Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV001577747 | SCV001805186 | likely benign | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV002573241 | SCV002126166 | likely benign | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2024-04-04 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003910904 | SCV004719570 | likely benign | EP300-related disorder | 2022-01-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |